Assessing Glaukos (GKOS) After Recent Share Price Rebound And DCF Upside Potential [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
If you are trying to figure out whether Glaukos at around US$119 per share is offering good value or asking too much, you are in the right place. The stock is up 7.8% over the last month, after a 23.7% decline over the past year and a 131.7% return over three years, which can change how the market views both its growth potential and its risk. Recent coverage around Glaukos has focused on its position in ophthalmic medical devices and procedures, as investors weigh how its product portfolio and market reach fit into long term demand for eye care. This context helps explain why the share price has moved in fits and starts rather than in a straight line. On our valuation checklist, Glaukos scores 2 out of 6 , which suggests some valuation methods flag potential value while others are less supportive. We will compare those approaches before finishing with a more complete way to think about what the stock might be worth. Glaukos scores just 2/6 on our valuation checks. See what ot
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- A Look At Glaukos (GKOS) Valuation After FDA Label Expansion For iDose TR [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To Glaukos (GKOS) FDA-Backed Repeat Protocol For iDose TR Implant [Yahoo! Finance]Yahoo! Finance
- Director Sells GKOS 15,000 Shares for $1.9 Million [Yahoo! Finance]Yahoo! Finance
- Wells sees potential upside after Glaukos' iDose repeat dosing label approved [Yahoo! Finance]Yahoo! Finance
- Glaukos (NYSE:GKOS) had its price target raised by analysts at BTIG Research from $123.00 to $131.00. They now have a "buy" rating on the stock.MarketBeat
GKOS
Earnings
- 10/29/25 - Beat
GKOS
Sec Filings
- 1/26/26 - Form 4
- 1/26/26 - Form 4
- 1/23/26 - Form 4
- GKOS's page on the SEC website